Live
Clinical OMICsTwo Women, One Mission: Closing the Gap Between Cancer Science and SurvivalEndpoints NewsTakeda fortifies orexin potential with more Phase 3 dataEndpoints NewsElicio’s KRAS cancer vaccine fails in Phase 2, shares plummetFierceBiotechAmid US investment tour, J&J makes $1B stop in Florida to upgrade contact lens plantEndpoints NewsGan & Lee's Phase 3 obesity successes; J&J touts multiple myeloma dataFierceBiotechAmgen loses in Harbour antibody patent case, ordered to pay $20M+FierceBiotechIntellia touts ‘paradigm-shifting’ phase 3 data for one-time HAE treatmentBioWorldElicio phase II results in pancreatic cancer wreck sharesBioWorldBiggest gainers and losers for June 8-12, 2026FierceBiotechNeumora to lay off 35% of staff after navacaprant goes 0 for 3 in late-stage depression studiesEndpoints NewsNeumora drug fails two more Phase 3 trials, biotech to lay off 35% of staffClinical OMICsRewriting Cancer Care Through Epigenetics

Archives

Récent Plus ancien Effacer
@BioWorld
Total 1506
Source BioWorld
Recherche --